Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 2/20 | 0.84 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.84 |
| ▸ | MMP3 | P08254 | 1/20 | 0.58 |
| ▸ | KIF11 | P52732 | 2/20 | 0.58 |
| ▸ | CA12 | O43570 | 2/20 | 0.48 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA9 | Q16790 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CYP11B2 | P19099 | 4/20 | 0.47 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.47 |
| ▸ | GAA | P10253 | 1/20 | 0.47 |
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.46 |
| ▸ | CA3 | P07451 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | AR | P10275 | 2/20 | 0.46 |
| ▸ | BCHE | P06276 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Water SCHEMBL28512959 | 1.00 | CYP2A6 (0.84) | CYP2A6ALDH1A1MMP3KIF11CA12 | |
| SCHEMBL91813 | 1.00 | CYP2A6 (0.84) | CYP2A6ALDH1A1MMP3KIF11CA12 | |
| SCHEMBL27329500 | 0.92 | CYP2A6 (1.00) | CYP2A6ALDH1A1MMP3KIF11CA12 | |
| P-Xylene SCHEMBL3926102 | 0.92 | CYP2A6 (1.00) | CYP2A6ALDH1A1MMP3KIF11CA12 | |
| SCHEMBL46818 | 0.92 | — | — | |
| SCHEMBL28089251 | 0.89 | CYP2A6 (0.94) | CYP2A6ALDH1A1MMP3KIF11CA12 | |
| SCHEMBL31070291 | 0.87 | ALDH1A1 (0.64) | CYP2A6ALDH1A1MMP3KIF11AR | |
| Cyanide SCHEMBL6561699 | 0.86 | CYP2A6 (0.89) | CYP2A6ALDH1A1MMP3KIF11CA12 | |
| Water SCHEMBL11055485 | 0.86 | MMP3 (0.74) | CYP2A6ALDH1A1MMP3KIF11CA12 | |
| SCHEMBL396846 | 0.86 | MMP3 (0.74) | CYP2A6ALDH1A1MMP3KIF11CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 117 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250011590-A1 | OPTICAL FILM AND POLARIZING PLATE | TOSOH CORPORATION (JP) | 2025-01-09 | — | — | US | disclosed |
| EP-4431989-A1 | OPTICAL FILM AND POLARIZING PLATE | Tosoh Corporation (JP) | 2024-09-18 | — | — | EP | disclosed |
| US-20240239934-A1 | FUMARIC ACID DIESTER RESIN, FILM AND POLARIZING PLATE | TOSOH CORPORATION (JP) | 2024-07-18 | — | — | US | disclosed |
| US-20240228878-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME | DIC CORPORATION (JP) | 2024-07-11 | — | — | US | disclosed |
| US-20240228878-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME | DIC CORPORATION (JP) | 2024-07-11 | — | — | US | disclosed |
| EP-4299283-A1 | FUMARIC ACID DIESTER RESIN, FILM AND POLARIZING PLATE | Tosoh Corporation (JP) | 2024-01-03 | — | — | EP | disclosed |
| US-20230399567-A1 | Liquid Crystal Element and Emulsion Composition | MITSUBISHI CHEMICAL CORPORATION (JP) | 2023-12-14 | — | — | US | disclosed |
| WO-2023090353-A1 | OPTICAL FILM AND POLARIZING PLATE | 東ソー株式会社 | 2023-05-25 | — | — | WO | disclosed |
| WO-2022210589-A1 | FUMARIC ACID DIESTER RESIN, FILM AND POLARIZING PLATE | 東ソー株式会社 | 2022-10-06 | — | — | WO | disclosed |
| EP-3944011-A1 | LIQUID-CRYSTAL DISPLAY | Merck Patent GmbH (DE) | 2022-01-26 | — | — | EP | disclosed |
| US-7678929-B2 | Furochroman derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2010-03-16 | — | — | US | disclosed |
| US-20090247620-A1 | Benzochromene Derivatives for Use in Liquid Crystal Media and as Therapeutic Active Substances | MERCK PATENT GMBH (DE) | 2009-10-01 | — | — | US | disclosed |
| US-20090023802-A1 | Benzochromene Derivatives | MERCK PATENT GMBH (DE) | 2009-01-22 | — | — | US | disclosed |
| EP-2006352-A1 | LIQUID-CRYSTAL COMPOSITION AND LIQUID-CRYSTAL ELEMENT | Chisso Corporation (JP) | 2008-12-24 | — | — | EP | disclosed |
| US-7440160-B2 | Electro-optical light modulating element, electro-optical display and modulating medium | MERCK PATENT GMBH (DE) | 2008-10-21 | — | — | US | disclosed |
| US-20080177095-A1 | FUROCHROMAN DERIVATIVES | MERCK PATENT GMBH (DE) | 2008-07-24 | — | — | US | disclosed |
| US-7361288-B2 | Components for high-frequency technology | MERCK PATENT GESELLSCHAFT MIT BESSCHRANKTER HAFTUNG (DE) | 2008-04-22 | — | — | US | disclosed |
| EP-1116770-B1 | NEMATIC LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY USING THE SAME | DAINIPPON INK & CHEMICALS (JP) | 2008-04-02 | — | — | EP | disclosed |
| US-7326447-B2 | Benzochromene derivatives | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2008-02-05 | — | — | US | disclosed |
| US-7314653-B2 | Liquid-crystal medium and electro-optical display containing same | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 2008-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080177095-A1 | FUROCHROMAN DERIVATIVES | CFD, LMAN1, UROD | CYP2A6 2847/4885ALDH1A1 1075/4885MMP3 1812/4885 |
| US-20090247620-A1 | Benzochromene Derivatives for Use in Liquid Crystal Media and as Therapeutic Active Substances | LPO, SBDS, OCIAD1 | CYP2A6 1448/4885ALDH1A1 1625/4885MMP3 3368/4885 |
| US-20090023802-A1 | Benzochromene Derivatives | SBDS, CRY1, DDT | CYP2A6 269/4885ALDH1A1 676/4885MMP3 3146/4885 |
| US-20240228878-A1 | COMPOUND, LIQUID CRYSTAL COMPOSITION, AS WELL AS LIQUID CRYSTAL DISPLAY ELEMENT, SENSOR, LIQUID CRYSTAL LENS, OPTICAL COMMUNICATION EQUIPMENT, AND ANTENNA EACH USING THE SAME | TTI2, CCT4, CCT2 | CYP2A6 4709/4885ALDH1A1 4223/4885MMP3 4557/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.